While these studies have led to a greater understanding of CD8+ T cell biology, most importantly they led to an important connection between Tcf-1 expression and CD8+ T cell responsiveness to PD-1-targeted checkpoint blockade therapy in cancer, which is discussed below. Here, CD8A is linked to cancer.